Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.60 |
| ▸ | NPY1R | P25929 | 2/20 | 0.56 |
| ▸ | NPY2R | P49146 | 2/20 | 0.56 |
| ▸ | NPY4R | P50391 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29440410 | 1.00 | ECE1 (0.60) | ECE1NPY1RNPY2RNPY4R | |
| SCHEMBL30799684 | 0.92 | ECE1 (0.64) | ECE1 | |
| SCHEMBL22133113 | 0.92 | ECE1 (0.64) | ECE1 | |
| SCHEMBL13725698 | 0.92 | ECE1 (0.64) | ECE1 | |
| SCHEMBL23178151 | 0.92 | ERAP1 (0.64) | ECE1 | |
| SCHEMBL30291268 | 0.90 | ECE1 (0.69) | ECE1NPY1RNPY2RNPY4R | |
| SCHEMBL5558360 | 0.90 | ECE1 (0.69) | ECE1NPY1RNPY2RNPY4R | |
| SCHEMBL31722484 | 0.88 | KDM4E (0.62) | ECE1 | |
| Hydrochloric Acid SCHEMBL8982603 | 0.87 | KDM4E (0.60) | ECE1 | |
| SCHEMBL6466771 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3500252-B1 | MODIFIED PEPTIDES FOR USE IN TREATING NEURODEGENERATIVE DISORDERS | NEURO BIO LTD (GB) | 2022-11-02 | — | — | EP | disclosed |
| US-20210094983-A1 | MODIFIED PEPTIDES FOR USE IN TREATING NEURODEGENERATIVE DISORDERS | NEURO-BIO LTD. (GB) | 2021-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210094983-A1 | MODIFIED PEPTIDES FOR USE IN TREATING NEURODEGENERATIVE DISORDERS | IAPP, NLN, APP | ECE1 774/4885NPY1R 180/4885NPY2R 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.